53044 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 13
00:18 UTC
|
INF
Informa
|
◎ Target | firm only | Buy | GBX 990→ GBX 1,090+10.1% |
|
Aug 13
00:18 UTC
|
IMNM
Immunome
|
◎ Target | Supawat Thongthip not yet tracked | Buy | $37.00→ $38.00+2.7% |
|
Aug 13
00:18 UTC
|
IMNM
Immunome
|
◎ Target | David Nierengarten ★★★☆☆ #2127 | Outperform | $31.00→ $35.00+12.9% |
|
Aug 13
00:18 UTC
|
IAG
Iamgold
|
◎ Target | Tanya Jakusconek ★★☆☆☆ #2297 | Sec→ r Perform | $22.00→ $23.00+4.5% |
|
Aug 13
00:18 UTC
|
HRB
H&R Block
|
◎ Target | Alexander Paris ★★☆☆☆ #2712 | Outperform | $50.00→ $60.00+20.0% |
|
Aug 13
00:18 UTC
|
HRB
H&R Block
|
◎ Target | George Kelly ★★☆☆☆ #2855 | Sell | $29.00→ $33.00+13.8% |
|
Aug 13
00:18 UTC
|
HPQ
HP
|
◎ Target | Michael Ng not yet tracked | Sell | $19.00→ $21.00+10.5% |
|
Aug 13
00:18 UTC
|
HMH
HMH
|
◎ Target | Stephen Gengaro ★★★☆☆ #2062 | Buy | $27.00→ $28.00+3.7% |
|
Aug 13
00:18 UTC
|
HLIO
Helios Technologies
|
◎ Target | Nathan Jones ★★★☆☆ #1652 | Buy | $93.00→ $95.00+2.2% |
|
Aug 13
00:18 UTC
|
HLIO
Helios Technologies
|
◎ Target | Tomohiko Sano ★★☆☆☆ #2560 | Overweight | $100.00→ $110.00+10.0% |
|
Aug 13
00:18 UTC
|
HIK
Hikma Pharmaceuticals
|
◎ Target | firm only | Buy | GBX 1,700→ GBX 1,870+10.0% |
|
Aug 13
00:18 UTC
|
HG
Hamilton Insurance Group
|
◎ Target | Tommy McJoynt not yet tracked | Outperform | $39.00→ $40.00+2.6% |
|
Aug 13
00:18 UTC
|
HD
Home Depot
|
◎ Target | Steven Shemesh ★★★★☆ #947 | Sec→ r Perform | $340.00→ $343.00+0.9% |
|
Aug 13
00:18 UTC
|
HBT
HBT Financial
|
◎ Target | firm only | Outperform | $40.00→ $44.00+10.0% |
|
Aug 13
00:18 UTC
|
HBIO
Harvard Bioscience
|
◎ Target | Bruce D. Jackson not yet tracked | Speculative Buy | $6.00→ $7.50+25.0% |
|
Aug 13
00:18 UTC
|
GPMT
Granite Point Mortgage Trust
|
◎ Target | Jade Rahmani ★★★☆☆ #1891 | Market Perform | $1.50→ $1.25-16.7% |
|
Aug 13
00:18 UTC
|
GLEN
Glencore
|
◎ Target | firm only | Buy | GBX 770→ GBX 780+1.3% |
|
Aug 13
00:18 UTC
|
GEN
Genuit Group
|
◎ Target | firm only | Overweight | GBX 440→ GBX 450+2.3% |
|
Aug 13
00:18 UTC
|
GEN
Genuit Group
|
◎ Target | firm only | Buy | GBX 332→ GBX 366+10.2% |
|
Aug 13
00:18 UTC
|
FR
First Industrial Realty Trust
|
◎ Target | Nicholas Yulico ★★★☆☆ #1462 | Sec→ r Perform | $63.00→ $66.00+4.8% |
|
Aug 13
00:18 UTC
|
FLY
Firefly Aerospace
|
◎ Target | Mike Crawford ★★☆☆☆ #2498 | Buy | $60.00→ $50.00-16.7% |
|
Aug 13
00:18 UTC
|
FLY
Firefly Aerospace
|
◎ Target | Suji Desilva ★★☆☆☆ #2853 | Buy | $60.00→ $45.00-25.0% |
|
Aug 13
00:18 UTC
|
FICO
Fair Isaac
|
◎ Target | Kevin McVeigh ★★★★☆ #570 | Neutral | $1,200.00→ $1,130.00-5.8% |
|
Aug 13
00:18 UTC
|
FENC
Adherex Technologies
|
◎ Target | David Nierengarten ★★★☆☆ #2127 | Outperform | $13.00→ $16.00+23.1% |
|
Aug 13
00:18 UTC
|
EXPE
Expedia Group
|
◎ Target | Stephen Ju ★★☆☆☆ #2489 | Neutral | $322.00→ $351.00+9.0% |
|
Aug 13
00:18 UTC
|
EXOD
Exodus Movement
|
◎ Target | Gareth Gacetta not yet tracked | Overweight | $14.00→ $15.00+7.1% |
|
Aug 13
00:18 UTC
|
EXE
Expand Energy
|
◎ Target | Subash Chandra ★★☆☆☆ #2577 | Buy | $124.00→ $109.00-12.1% |
|
Aug 13
00:18 UTC
|
EVH
Evolent Health
|
◎ Target | Jailendra Singh ★★★★★ #262 | Hold | $7.00→ $6.00-14.3% |
|
Aug 13
00:18 UTC
|
EVEX
EVE
|
◎ Target | Marcelo Motta not yet tracked | Overweight | $6.00→ $6.50+8.3% |
|
Aug 13
00:18 UTC
|
ETOR
eToro Group
|
◎ Target | Alex Kramm ★★★★★ #146 | Neutral | $50.00→ $35.00-30.0% |
|
Aug 13
00:18 UTC
|
ETOR
eToro Group
|
◎ Target | Chris Allen not yet tracked | Market Perform | $45.00→ $35.00-22.2% |
|
Aug 13
00:18 UTC
|
ETOR
eToro Group
|
◎ Target | Nathan Frankovitz not yet tracked | Overweight | $61.00→ $53.00-13.1% |
|
Aug 13
00:18 UTC
|
ETOR
eToro Group
|
◎ Target | John Todaro ★☆☆☆☆ #3200 | Buy | $66.00→ $53.00-19.7% |
|
Aug 13
00:18 UTC
|
ETOR
eToro Group
|
◎ Target | Dan Dolev ★★★☆☆ #1904 | Outperform | $60.00→ $52.00-13.3% |
|
Aug 13
00:18 UTC
|
ETOR
eToro Group
|
◎ Target | James Yaro ★★★☆☆ #1413 | Neutral | $42.00→ $36.00-14.3% |
|
Aug 13
00:18 UTC
|
ET
Energy Transfer
|
◎ Target | Gabe Daoud not yet tracked | Buy | $23.00→ $25.00+8.7% |
|
Aug 13
00:18 UTC
|
EROK
EagleRock Land
|
◎ Target | Theresa Chen ★★★☆☆ #1443 | Overweight | $25.00→ $27.00+8.0% |
|
Aug 13
00:18 UTC
|
ERAS
Erasca
|
◎ Target | Andres Y. Maldonado ★★☆☆☆ #2664 | Buy | $18.00→ $22.00+22.2% |
|
Aug 13
00:18 UTC
|
ELVA
Electrovaya
|
◎ Target | Colin Rusch ★☆☆☆☆ #3145 | Outperform | $14.00→ $13.00-7.1% |
|
Aug 13
00:18 UTC
|
ELM
Elementis
|
◎ Target | firm only | Neutral | GBX 186→ GBX 190+2.2% |
|
Aug 13
00:18 UTC
|
ELE
Elemental Royalty
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $32.50→ $33.00+1.5% |
|
Aug 13
00:18 UTC
|
EIF
Exchange Income
|
◎ Target | firm only | Buy | C$135.00→ C$145.00+7.4% |
|
Aug 13
00:18 UTC
|
EE
Excelerate Energy
|
◎ Target | Praneeth Satish ★★★☆☆ #1996 | Equal Weight | $37.00→ $38.00+2.7% |
|
Aug 13
00:18 UTC
|
EAT
Brinker International
|
◎ Target | Andrew M. Charles not yet tracked | Buy | $210.00→ $270.00+28.6% |
|
Aug 13
00:18 UTC
|
DRX
Drax Group
|
◎ Target | firm only | Buy | GBX 920→ GBX 870-5.4% |
|
Aug 13
00:18 UTC
|
DRIO
DarioHealth
|
◎ Target | Charles Rhyee ★★★★☆ #390 | Hold | $11.00→ $8.00-27.3% |
|
Aug 13
00:18 UTC
|
DPC
DPC
|
◎ Target | Kristine Liwag ★★★☆☆ #1981 | Equal Weight | $47.00→ $59.00+25.5% |
|
Aug 13
00:18 UTC
|
DPC
DPC
|
◎ Target | Ken Herbert not yet tracked | Outperform | $53.00→ $62.00+17.0% |
|
Aug 13
00:18 UTC
|
DOM
Domino's Pizza Group
|
◎ Target | firm only | Underweight | GBX 145→ GBX 167+15.2% |
|
Aug 13
00:18 UTC
|
DFTX
Definium Therapeutics
|
◎ Target | Ami Fadia ★★★☆☆ #1953 | Buy | $50.00→ $66.00+32.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.